Business Context and Reporting Period
Company: Nanophase Technologies Corporation (Note: Metadata listed "SOLESENCE, INC." but filing text confirms "Nanophase Technologies Corporation").
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2008
Business Overview: Nanophase is a nanomaterials developer and commercial manufacturer producing engineered nanomaterials for markets including sunscreens, personal care, architectural coatings, industrial coatings, and semiconductor polishing (CMP). The company operates as a single business segment with all long-lived assets located in the United States.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2008 | Six Months Ended June 30, 2008 |
|---|---|---|
| Net Revenue | $2,944,406 | $5,998,514 |
| Gross Profit | $1,108,130 | $2,162,030 |
| Gross Margin | 37.6% | 36.0% |
| Net Loss | $(787,983) | $(1,735,810) |
| Loss Per Share (Basic/Diluted) | $(0.04) | $(0.08) |
| Cash and Cash Equivalents | $908,493 (as of June 30, 2008) | N/A |
| Total Investments | $14,881,386 (Short-term: $8.88M; Long-term: $6.0M) | N/A |
| Long-Term Debt | $1,540,703 (net of discount) | N/A |
| Working Capital | $10,653,164 | N/A |
Liquidity: As of June 30, 2008, the company held approximately $15.8 million in cash, cash equivalents, and investments. Net cash used in operating activities for the six months ended June 30, 2008, was $683,311, an improvement from $1.59 million used in the prior year period.
Material Changes vs. Prior Period
- Revenue Decline: Net revenue decreased 28.6% for the three months and 14.7% for the six months ended June 30, 2008, compared to the same periods in 2007. This was primarily driven by decreased sales to the company's largest customer (attributed to inventory issues) and a decline in sales to architectural coatings customers (impacted by the housing market).
- Expense Trends: Cost of revenue decreased due to lower volume and reduced commodity metal pricing. Research and development expenses decreased due to lower salaries and testing costs. However, Selling, General, and Administrative (SG&A) expenses increased due to patent write-offs, stock compensation, and professional fees.
- Investment Reclassification: $6 million of auction rate securities (ARS) were reclassified from short-term to long-term investments due to "failed auctions" and uncertainty regarding liquidity, though no permanent decline in value was identified.
- Patent Write-off: The company recorded a write-off of approximately $131,000 following the cancellation of claims in a patent re-examination by the USPTO.
Guidance, Outlook, Risks, and Contingencies
- Outlook: Management expects growth in end-user adoption in CMP and fine polishing markets in 2008 and beyond. The company anticipates developing additional customers to achieve growth in 2009. Capital spending for the remainder of 2008 is expected to be approximately $500,000.
- Customer Concentration Risk: Three customers accounted for approximately 86% of revenue for the three months ended June 30, 2008 (37%, 32%, and 17%).
- Supply Agreement Contingencies: The supply agreement with BASF (largest customer) contains financial covenants. A "triggering event" (e.g., negative earnings combined with cash/investments under $2 million, or debt acceleration) could force the company to license technology and sell production equipment to BASF. The company currently believes it has sufficient liquidity to avoid this trigger.
- Liquidity Risk: While the company has $15.8 million in liquid assets, $6 million is tied up in auction rate securities with failed auctions. Management believes these are AAA-rated and guaranteed by the Department of Education, but liquidity may be constrained between auctions.
- Patent Risk: The cancellation of claims in US Patent No. 6,669,823 B1 limits the company's ability to assert infringement claims regarding its NanoArc Synthesis process, though management does not believe this materially alters the competitive environment.
Investor Verification Checklist
- Auction Rate Securities Liquidity: Verify the current status of the $6 million in failed auction rate securities and the company's ability to access these funds if needed to meet the $2 million liquidity covenant with BASF.
- Customer Concentration: Assess the stability of the top three customers, particularly the largest customer (BASF), given the significant revenue decline and the specific contractual risks associated with their supply agreement.
- Patent Portfolio: Review the status of the pending continuation and divisional patent applications intended to replace the cancelled claims in US Patent No. 6,669,823 B1.
- Operating Cash Flow: Monitor the trend in net cash used in operating activities to ensure it remains manageable relative to the company's cash reserves.
- Inventory Levels: Review the increase in net inventories ($1.57 million vs. $1.09 million at year-end 2007) and the allowance for excess inventory to ensure no further write-downs are necessary.